What is the 13F Pro Quality Score for OMCL?

13F Pro ranks OMNICELL, INC. (OMCL) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View OMCL's current score at https://13fpro.ai/research/OMCL (free sign-up required for the full ranking).

Where does 13F Pro source OMCL data?

All OMNICELL, INC. fundamentals and ownership data come directly from SEC EDGAR. OMNICELL, INC. files with the SEC under CIK 926326. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is OMCL in?

OMNICELL, INC. (OMCL) is classified in the Technology sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/technology.

How often is OMCL research updated on 13F Pro?

OMCL's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

OMNICELL, INC.(OMCL)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Technology →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 926326 OMCL stock profile & AI dashboard →

13F Pro Quality Score

45.6/100

Rank #1,706 of 2,879 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

39.9/100

Profitability

45.4/100

Balance Sheet

41.6/100

Earnings Quality

30.0/100

Free Cash Flow

61.1/100

Institutional Flow

45.5/100

Revenue Scale

52.6/100

Dilution Risk

30.1/100

OMCL Stock Analysis & AI Quality Score

AI stock analysis and institutional research for OMNICELL, INC. (OMCL), a Technology sector company. 13F Pro's AI-powered ranking engine scores OMCL at 45.6/100 on a 32-signal composite quality model, placing it at rank #1,706 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (30.0) and revenue growth (39.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 30.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), OMNICELL, INC. reports quarterly revenue of $309.9M, net income of $11.4M, an operating margin of 5.4%. Top institutional holders of OMCL by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, WELLINGTON MANAGEMENT GROUP LLP, based on the most recent SEC filings. OMCL trades on the Nasdaq exchange and files with the SEC under CIK 926326. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OMCL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OMNICELL, INC. directly from SEC EDGAR. OMNICELL, INC.'s 13F Pro composite quality score has ranged between 8 and 63 since 2021, currently 45.6 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.

✦

Fun facts about OMNICELL, INC.

Quirks, history, and lore behind OMCL — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare technology company · listed on Nasdaq · serves hospitals, health systems, and pharmacies · headquartered in Texas.
2
The Numbers
Annual revenue in the neighborhood of $1 billion, with a customer base spanning thousands of healthcare facilities across North America and beyond.
3
The History
Founded in the 1990s in California, the company set out to automate one of the most error-prone tasks in medicine: getting the right medication to the right patient.
4
The Secret
Its real product isn't pills — it's the robotic cabinets, software, and analytics that make sure pills don't go missing, get wasted, or hurt anyone.
5
The Lore
Its automated dispensing cabinets sit on nursing floors nationwide, essentially acting as a high-security vending machine for controlled substances — with a full audit trail.
6
The Giveaway
If a hospital pharmacist says the word "the cabinet", there's a good chance they mean one of this company's machines — it's the dominant name in pharmacy automation and trades under a ticker that rhymes with "miracle."

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$309.9M

Net Income

Q1 2026

$11.4M

Free Cash Flow

Q1 2026

$42.1M

Operating Margin

Q1 2026

5.4%

ROIC

Q1 2026

1.3%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+3.3% YoY

$1.18BFY 2025

FY21 $1.13BFY22 $1.30BFY23 $1.15BFY25 $1.18B

Net Income

+110.1% YoY

$2.1MFY 2025

FY21 $77.8MFY22 $5.6MFY23 $-20.4MFY25 $2.1M

Operating Income

+114.8% YoY

$5.2MFY 2025

FY21 $89.5MFY22 $-2.3MFY23 $-34.9MFY25 $5.2M

EPS (Diluted)

+108.9% YoY

$0.04FY 2025

FY21 $1.62FY22 $0.12FY23 $-0.45FY25 $0.04

Total Assets

-11.3% YoY

$1.97BFY 2025

FY21 $2.14BFY22 $2.21BFY23 $2.23BFY25 $1.97B

Total Debt

—FY 2025

FY21 —FY22 —FY23 —FY25 —

Op. Cash Flow

-29.7% YoY

$127.3MFY 2025

FY21 $231.8MFY22 $77.8MFY23 $181.1MFY25 $127.3M

Metric	FY 2025	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Revenue	$1.18B +3.3%	$1.15B -11.5%	$1.30B +14.5%	$1.13B +26.9%	$892.2M -0.5%	$897.0M
Net Income	$2.1M +110.1%	$-20.4M -460.7%	$5.6M -92.7%	$77.8M +141.8%	$32.2M -47.5%	$61.3M
Operating Income	$5.2M +114.8%	$-34.9M -1401.0%	$-2.3M -102.6%	$89.5M +151.9%	$35.5M -54.7%	$78.4M
EPS (Diluted)	$0.04 +108.9%	$-0.45 -475.0%	$0.12 -92.6%	$1.62 +118.9%	$0.74 -48.3%	$1.43
Total Assets	$1.97B -11.3%	$2.23B +0.7%	$2.21B +3.2%	$2.14B +17.4%	$1.82B +47.0%	$1.24B
Total Debt	—	—	—	—	—	$50.0M
Operating Cash Flow	$127.3M -29.7%	$181.1M +132.8%	$77.8M -66.4%	$231.8M +24.7%	$185.9M +28.2%	$145.0M

AI Insight: OMCL Financial Trends

Omnicell shows volatile profitability with Q1 2026 operating income rebounding to $17M after break-even Q4 2025.

• Revenue grew from $270M in Q1 2025 to $310M in Q1 2026, a 15% year-over-year increase.

• Operating income recovered to $17M in Q1 2026 from $0M in Q4 2025 and negative $12M in Q1 2025.

• Operating cash flow remains volatile, ranging from $23M to $59M across the eight quarters.

⚠ Net income turned negative in Q1 2025 and Q4 2025 despite positive operating income in most quarters.

⚠ Equity declined from $1,264M in Q2 2025 to $1,221M in Q3 2025, the largest quarterly drop observed.

AI Insight: OMCL Ratio Trends

Omnicell shows extreme quarterly volatility with operating margin swinging from -4.3% in Q1 2025 to 5.4% in Q1 2026.

• Operating margin improved dramatically from 0.1% in Q4 2025 to 5.4% in Q1 2026.

• ROIC rebounded from 0.1% in Q4 2025 to 5.4% in Q1 2026, highest level in dataset.

• Net profit margin turned positive at 3.7% in Q1 2026 after -0.7% loss in Q4 2025.

⚠ Profitability remains highly volatile with negative margins in Q1 2025 and Q4 2025 amid positive quarters.

⚠ TTM operating margin of 2.8% lags the strong 5.4% quarterly performance in Q1 2026.

Get alerted when OMCL's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for OMNICELL, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of OMCL

BlackRock, Inc.
$240.6M7,207,218 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$107.3M3,214,766 sh
WELLINGTON MANAGEMENT GROUP LLP
$90.4M2,707,046 sh
DIMENSIONAL FUND ADVISORS LP
$81.8M2,450,385 sh
MILLENNIUM MANAGEMENT LLC
$76.4M2,288,570 sh
STATE STREET CORP
$65.1M1,950,539 sh
VANGUARD CAPITAL MANAGEMENT LLC
$64.6M1,934,517 sh
LINDEN ADVISORS LP
$62.8M64,400,000 sh
LAZARD ASSET MANAGEMENT LLC
$49.1M1,470,074 sh
Sumitomo Mitsui Trust Holdings, Inc.
$47.1M1,410,865 sh

Fund	Value	Shares
BlackRock, Inc.	$240.6M	7,207,218
VANGUARD PORTFOLIO MANAGEMENT LLC	$107.3M	3,214,766
WELLINGTON MANAGEMENT GROUP LLP	$90.4M	2,707,046
DIMENSIONAL FUND ADVISORS LP	$81.8M	2,450,385
MILLENNIUM MANAGEMENT LLC	$76.4M	2,288,570
STATE STREET CORP	$65.1M	1,950,539
VANGUARD CAPITAL MANAGEMENT LLC	$64.6M	1,934,517
LINDEN ADVISORS LP	$62.8M	64,400,000
LAZARD ASSET MANAGEMENT LLC	$49.1M	1,470,074
Sumitomo Mitsui Trust Holdings, Inc.	$47.1M	1,410,865

More Technology Companies

View all Technology →

AGILENT TECHNOLOGIES, INC.

AAOI

APPLIED OPTOELECTRONICS, INC.

AAPL

Apple Inc.

ABNB

Airbnb, Inc.

ACCL

Acco Group Holdings Ltd

ACCS

ACCESS Newswire Inc.

ACFN

ACORN ENERGY, INC.

ACIW

ACI WORLDWIDE, INC.

Put OMCL on your watchlist

Track score changes the day OMNICELL, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is OMCL a good stock to buy?

13F Pro's AI-powered analysis of OMNICELL, INC. (OMCL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OMCL are available on the OMCL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own OMCL?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OMCL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of OMNICELL, INC.'s investment landscape.